Retrospective Study
Copyright ©The Author(s) 2025.
World J Virol. Mar 25, 2025; 14(1): 100501
Published online Mar 25, 2025. doi: 10.5501/wjv.v14.i1.100501
Figure 3
Figure 3 Percentage of multidrug-resistant. A: Enterobacterales: From extended-spectrum beta-lactamases to Carbapenemases; B: Acinetobacter and Pseudomonas; C: Gram-positive Bacteria. CRE: Carbapenem-resistant; CRP: Carbapenem-resistant Pseudomonas aeruginosa; E. coil: Escherichia coli; ESBL: Extended-spectrum beta-lactamases; MDR: Multidrug-resistant; MRSA: Methicillin-resistant Staphylococcus aureus; VRE: Vancomycin-resistant Enterococci.